- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03270449
Community-based Intervention for Fibromyalgia: A Pilot Trial
7 oktober 2019 bijgewerkt door: Nelly Oelke, University of British Columbia
A Multi-disciplinary, Community-based Group Intervention for Fibromyalgia: A Pilot Randomized Controlled Trial
Fibromyalgia (FM) is a multi-factorial chronic pain condition characterized by fluctuating and heterogeneous symptoms.
This leads to both reduced patient function and quality of life and consequentially, significant economic burden on the society.
Although numerous pharmaceutical and multi-treatment approaches exist, there is lack of an integrated multidisciplinary model of care for these patients.
Such a system is hypothesized to be beneficial for the patients and would help them regain function and significantly improve their quality of life.
The primary aim of this pilot clinical trial is to evaluate the effectiveness of an integrated community-based multidisciplinary model of care for FM patients in Penticton and surrounding areas.
The comprehensive 10 week intervention will provide care from a team of health care providers (psychiatrist, physiotherapist, certified exercise therapist, dietitian, rheumatologist, and mental health clinician).
Patients will also attend a peer led pain self-management support group provided by the Arthritis Society.
The study aims at educating these patients about self-management of their symptoms such as chronic pain, weight, sleep and mood disorders.
The integration of health care between the different providers will be achieved by "huddle" sessions that will be conducted on a monthly basis.
The evaluation of the study outcomes will be based on the RE-AIM framework.
Data will be collected through patient questionnaires, healthcare utilization data, and interviews with providers.
Data analysis will involve thematic analysis of qualitative data and statistical methods for quantitative data.
Studie Overzicht
Toestand
Voltooid
Conditie
Interventie / Behandeling
Studietype
Ingrijpend
Inschrijving (Werkelijk)
84
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
British Columbia
-
Penticton, British Columbia, Canada, V2A 4Z1
- Balfour Medical Centre
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
19 jaar en ouder (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- formal diagnosis of FM
- resident of Penticton or surrounding area
- adults, aged 19 and older
- fluent in English or bring a family member/friend to assist with translation
- capacity to provide informed consent
Exclusion Criteria:
- patients with a severe and/or chronic medical or psychiatric condition that would impact ability to participate in the intervention
- patients who are pregnant or lactating
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: Multidisciplinary intervention
The 10-week intervention will include twice weekly 1-2 hours sessions with multiple professional team members to undergo education and exercise sessions.
The multidisciplinary team will consist of a rheumatologist, rheumatology nurse, dietitian, physiotherapist, a trained exercise therapist, a physiologist who specializes in pain management, a psychiatrist and a mental health clinician.
All intervention team members have expertise in working with individuals with chronic pain conditions.
General disease information, current best practices and techniques such as self-pain management, pacing, sleep hygiene, approach to a healthy lifestyle and weight loss will be discussed.
The total number of hours for the 10 week intervention is 31 hours.
|
10 week multidisciplinary education and exercise
|
Geen tussenkomst: Usual care
Usual care involves being referred to the local rheumatologist involved in the study.
The rheumatologist and the rheumatology nurse will see the control group patients during a one hour one on one consultation appointment.
During that time the patient's history will be taken, physical exam performed and investigations analyzed.
If a diagnosis of fibromyalgia is confirmed, the rheumatologist and nurse will counsel the patient and provide resources for self directed management.
Unless there is a concern of an alternative diagnosis, follow up will not be arranged.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Patient-perceived quality of care
Tijdsspanne: Change from baseline in perceived quality of care at 10 weeks and 6 months
|
Patient assessment of care received as measured by the Patient Assessment of Chronic Illness Care Questionnaire
|
Change from baseline in perceived quality of care at 10 weeks and 6 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Daily function #1
Tijdsspanne: Change from baseline in daily function at 10 weeks and 6 months
|
Physical disease and mental health related functioning as measured by Revised-Fibromyalgia Impact Questionnaire
|
Change from baseline in daily function at 10 weeks and 6 months
|
Daily function #2
Tijdsspanne: Change from baseline in daily function at 10 weeks and 6 months
|
Mental health related functioning as measured by Hospital Anxiety and Depression scale
|
Change from baseline in daily function at 10 weeks and 6 months
|
Health care utilization (physician visits)
Tijdsspanne: Change from baseline in physician visits at 6 months
|
Number of physician visits
|
Change from baseline in physician visits at 6 months
|
Health care utilization (emergency visits)
Tijdsspanne: Change from baseline in emergency department visits at 6 months
|
Number of emergency department visits
|
Change from baseline in emergency department visits at 6 months
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Sleep quality
Tijdsspanne: Change from baseline in sleep quality at 10 weeks
|
Quality of sleep as measured by Sleep scale - medical outcome scale
|
Change from baseline in sleep quality at 10 weeks
|
Sleep quality
Tijdsspanne: Change from baseline in sleep quality at 6 months
|
Quality of sleep as measured by Sleep scale - medical outcome scale
|
Change from baseline in sleep quality at 6 months
|
Attitudes of pain
Tijdsspanne: Change from baseline in pain attitudes at 10 weeks and 6 months
|
Measurement of pain through Survey of brief attitudes of pain
|
Change from baseline in pain attitudes at 10 weeks and 6 months
|
Irritability
Tijdsspanne: Change from baseline in irritability at 10 weeks
|
Irritability measured by Brief Irritability Test (BITe) questionnaire
|
Change from baseline in irritability at 10 weeks
|
Irritability
Tijdsspanne: Change from baseline in irritability at 6 months
|
Irritability measured by Brief Irritability Test (BITe) questionnaire
|
Change from baseline in irritability at 6 months
|
Patient perspectives on self-management resources
Tijdsspanne: 10 weeks
|
Questionnaire to be administered to gather patient perspectives on self-management resources offered via hard copy, online, and social media
|
10 weeks
|
Patient perspectives on self-management resources
Tijdsspanne: 6 months
|
Questionnaire to be administered to gather patient perspectives on self-management resources offered via hard copy, online, and social media
|
6 months
|
Provider perspectives on quality of care
Tijdsspanne: 18 months
|
Interviews will be conducted to gather providers' perspectives on the model of care
|
18 months
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Onderzoekers
- Hoofdonderzoeker: Michelle Teo, University of British Columbia
Publicaties en nuttige links
De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.
Algemene publicaties
- Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120. doi: 10.1186/ar2783. Epub 2009 Aug 10. Erratum In: Arthritis Res Ther. 2009;11(5):415.
- Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choiniere M, Ko G, Moulin DE, Panopalis P, Proulx J, Shir Y; National Fibromyalgia Guideline Advisory Panel. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013 May-Jun;18(3):119-26. doi: 10.1155/2013/918216.
- Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D, Gerwin R, Zlateva G. The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes. 2011 Aug 22;9:71. doi: 10.1186/1477-7525-9-71.
- Lachaine J, Beauchemin C, Landry PA. Clinical and economic characteristics of patients with fibromyalgia syndrome. Clin J Pain. 2010 May;26(4):284-90. doi: 10.1097/AJP.0b013e3181cf599f.
- Thompson JM, Luedtke CA, Oh TH, Shah ND, Long KH, King S, Branda M, Swanson R. Direct medical costs in patients with fibromyalgia: Cost of illness and impact of a brief multidisciplinary treatment program. Am J Phys Med Rehabil. 2011 Jan;90(1):40-6. doi: 10.1097/PHM.0b013e3181fc7ff3.
- Winkelmann A, Perrot S, Schaefer C, Ryan K, Chandran A, Sadosky A, Zlateva G. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy. 2011 Mar 1;9(2):125-36. doi: 10.2165/11535250-000000000-00000.
- Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012;2012:426130. doi: 10.1155/2012/426130. Epub 2012 Nov 4. Erratum In: Pain Res Treat. 2013;2013:960270.
- Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013 Jun;103(6):e38-46. doi: 10.2105/AJPH.2013.301299. Epub 2013 Apr 18.
- Richards L, Morse J. Read me first for a users guide to qualitative methods. (3rd ed.) Sage Publications, Inc. 2013.
- Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. Springer Science & Business Media; 2009.
- Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care. 2005 May;43(5):436-44. doi: 10.1097/01.mlr.0000160375.47920.8c.
- Nam S, Tin D, Bain L, Thorne JC, Ginsburg L. Clinical utility of the Hospital Anxiety and Depression Scale (HADS) for an outpatient fibromyalgia education program. Clin Rheumatol. 2014 May;33(5):685-92. doi: 10.1007/s10067-013-2377-1. Epub 2013 Sep 1.
- Cappelleri JC, Bushmakin AG, McDermott AM, Dukes E, Sadosky A, Petrie CD, Martin S. Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia. Sleep Med. 2009 Aug;10(7):766-70. doi: 10.1016/j.sleep.2008.09.004. Epub 2009 Jan 29.
- Tait RC, Chibnall JT. Development of a brief version of the Survey of Pain Attitudes. Pain. 1997 Apr;70(2-3):229-35. doi: 10.1016/s0304-3959(97)03330-7.
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
15 september 2017
Primaire voltooiing (Werkelijk)
30 juni 2019
Studie voltooiing (Werkelijk)
30 juni 2019
Studieregistratiedata
Eerst ingediend
21 augustus 2017
Eerst ingediend dat voldeed aan de QC-criteria
31 augustus 2017
Eerst geplaatst (Werkelijk)
1 september 2017
Updates van studierecords
Laatste update geplaatst (Werkelijk)
9 oktober 2019
Laatste update ingediend die voldeed aan QC-criteria
7 oktober 2019
Laatst geverifieerd
1 oktober 2019
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- H17-01782
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Multidisciplinary intervention
-
The University of Texas Health Science Center,...National Center for Advancing Translational Sciences (NCATS)Actief, niet wervend
-
Henry Ford Health SystemBlue Cross Blue Shield of Michigan FoundationVoltooidDiabetes mellitus, type 2Verenigde Staten
-
Idaho State UniversityNog niet aan het wervenGegamificeerde digitale interventie om de effectiviteit van exposure-therapie voor OCS te verbeterenExperimentele videogames | Gedragsbeoordeling
-
Vanderbilt UniversityAanmelden op uitnodigingMoeilijkheden bij het leren van wiskundeVerenigde Staten
-
National and Kapodistrian University of AthensUniversity of Thessaly; Aghia Sophia Children's Hospital of Athens; National Hellenic... en andere medewerkersVoltooidDiabetes mellitus type 2 | Telomeer verkortingGriekenland
-
University of SurreySurrey and Borders Partnership NHS Foundation TrustWervingAanhoudende depressieve stoornisVerenigd Koninkrijk
-
Washington University School of MedicineSt. Jude Children's Research HospitalVoltooidKanker bij kinderen | Kinderkanker | Cardiale toxiciteitVerenigde Staten
-
VA Office of Research and DevelopmentVoltooidPrediabetesVerenigde Staten
-
Hackensack Meridian HealthAmerican Music Therapy AssociationWervingSchizofreniespectrum en andere psychotische stoornissen | Bipolaire stoornis | Angststoornis | Geestelijke gezondheidsproblemen | DepressiefVerenigde Staten
-
Evgenia E. PsarrakiVoltooidErnstige depressieve stoornisGriekenland